Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Professor Diana Sarfati

PositionCo-Head of Department and Professor
DepartmentDepartment of Public Health (UOW)
QualificationsMB ChB MPH FAFPHM
Research summaryCancer epidemiology

Research

Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM) is a public health physician and epidemiologist with a particular interest in the interface between public health and clinical medicine. She is co-Head of the Department of Public Health and the Director of the Cancer and Chronic Conditions (C3) research group.

Professor Sarfati has a range of research interests relating to cancer, long term conditions and health services. She has led a large body of work relating to ethnic disparities in cancer outcomes. This work has resulted in the identification of key patient and health system factors that influence cancer survival. This work has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes.

Her work in screening has included both research and policy elements. She is a member of the National Screening Advisory Group, and past member of the Bowel Cancer Screening Taskforce, and the National Bowel Cancer Working Group. She has written many academic papers relating to screening and is currently leading work on the benefits and harms of rheumatic heart disease screening.

Multimorbidity is the co-existence of long-term medical conditions. Multimorbidity is common, particularly among those aged over 65 years, Māori and Pacific people and those living in socioeconomic deprivation. Professor Sarfati has a strong interest in research focused on multimorbidity in general, and in the context of cancer specifically. Her research focuses on the role of health services in improving outcomes for people with a range of health-related conditions.

Publications

Stanley, J., & Sarfati, D. (2017). The new Measuring Multimorbidity index predicted mortality better than Charlson and Elixhauser indices amongst the general population. Journal of Clinical Epidemiology. Advance online publication. doi: 10.1016/j.jclinepi.2017.08.005

Ginsburg, O., Badwe, R., Boyle, P., Derricks, G., Dare, A., Evans, T., … Sarfati, D., … Sullivan, R. (2017). Changing global policy to deliver safe, equitable, and affordable care for women's cancers. Lancet, 389(10071), 871-880. doi: 10.1016/s0140-6736(16)31393-9

McLeod, M., Kvizhinadze, G., Boyd, M., Barendregt, J., Sarfati, D., Wilson, N., & Blakely, T. (2017). Colorectal cancer screening: How health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age-range to screen. Cancer Epidemiology, Biomarkers & Prevention. Advance online publication. doi: 10.1158/1055-9965.epi-17-0150

Gurney, J. K., Kersting, U. G., Rosenbaum, D., Dissanayake, A., York, S., Grech, R., … Sarfati, D. (2017). Pedobarography as a clinical tool in the management of diabetic feet in New Zealand: A feasibility study. Journal of Foot & Ankle Research, 10, 24. doi: 10.1186/s13047-017-0205-6

Gurney, J., Richiardi, L., McGlynn, K. A., Signal, V., & Sarfati, D. (2017). Analgesia use during pregnancy and risk of cryptorchidism: A systematic review and meta-analysis. Human Reproduction. Advance online publication. doi: 10.1093/humrep/dex047

Authored Book - Other

Sarfati, D., & Scott, K. (1999). Taking the Pulse: the 1996/97 New Zealand Health Survey. Wellington: Ministry of Health.

^ Top of page

Chapter in Book - Research

Sarfati, D., & Gurney, J. (2016). What is comorbidity? In B. Koczwara (Ed.), Cancer and chronic conditions: Addressing the problem of multimorbidity in cancer patients and survivors. (pp. 1-33). Springer. doi: 10.1007/978-981-10-1844-2

Sarfati, D. (2016). How do we measure comorbidity? In B. Koczwara (Ed.), Cancer and chronic conditions: Addressing the problem of multimorbidity in cancer patients and survivors. (pp. 35-70). Springer. doi: 10.1007/978-981-10-1844-2

Fleming, S. T., Sarfati, D., Kimmick, G., Schoenberg, N., & Cunningham, R. (2016). Impact of comorbidity on cancer screening and diagnosis. In B. Koczwara (Ed.), Cancer and chronic conditions: Addressing the problem of multimorbidity in cancer patients and survivors. (pp. 105-129). Springer. doi: 10.1007/978-981-10-1844-2

^ Top of page

Journal - Research Article

Stanley, J., & Sarfati, D. (2017). The new Measuring Multimorbidity index predicted mortality better than Charlson and Elixhauser indices amongst the general population. Journal of Clinical Epidemiology. Advance online publication. doi: 10.1016/j.jclinepi.2017.08.005

Gurney, J., Richiardi, L., McGlynn, K. A., Signal, V., & Sarfati, D. (2017). Analgesia use during pregnancy and risk of cryptorchidism: A systematic review and meta-analysis. Human Reproduction. Advance online publication. doi: 10.1093/humrep/dex047

Gurney, J. K., Kersting, U. G., Rosenbaum, D., Dissanayake, A., York, S., Grech, R., … Sarfati, D. (2017). Pedobarography as a clinical tool in the management of diabetic feet in New Zealand: A feasibility study. Journal of Foot & Ankle Research, 10, 24. doi: 10.1186/s13047-017-0205-6

McLeod, M., Kvizhinadze, G., Boyd, M., Barendregt, J., Sarfati, D., Wilson, N., & Blakely, T. (2017). Colorectal cancer screening: How health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age-range to screen. Cancer Epidemiology, Biomarkers & Prevention. Advance online publication. doi: 10.1158/1055-9965.epi-17-0150

Ginsburg, O., Badwe, R., Boyle, P., Derricks, G., Dare, A., Evans, T., … Sarfati, D., … Sullivan, R. (2017). Changing global policy to deliver safe, equitable, and affordable care for women's cancers. Lancet, 389(10071), 871-880. doi: 10.1016/s0140-6736(16)31393-9

Signal, L., Semper, K., Stairmand, J., Davies, C., Millar, E., Dowell, T., … Mangin, D., & Sarfati, D. (2017). A walking stick in one hand and a chainsaw in the other: Patients’ perspectives of living with multimorbidity. New Zealand Medical Journal, 130(1455), 65-76. Retrieved from https://www.nzma.org.nz/journal

Gurney, J. K., Stanley, J., Baker, M. G., Wilson, N. J., & Sarfati, D. (2016). Estimating the risk of acute rheumatic fever in New Zealand by age, ethnicity and deprivation. Epidemiology & Infection, 144(14), 3058-3067. doi: 10.1017/s0950268816001291

Sarfati, D., Gurney, J., Lim, B. T., Bagheri, N., Simpson, A., Koea, J., & Dennett, E. (2016). Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival. Asia-Pacific Journal of Clinical Oncology, 12(1), e47-e56. doi: 10.1111/ajco.12130

Wernham, E., Gurney, J., Stanley, J., Ellison-Loschmann, L., & Sarfati, D. (2016). A comparison of midwife-led and medical-led models of care and their relationship to adverse fetal and neonatal outcomes: A retrospective cohort study in New Zealand. PLoS Medicine, 13(9), e1002134. doi: 10.1371/journal.pmed.1002134

Lawrenson, R., Lao, C., Elwood, M., Brown, C., Sarfati, D., & Campbell, I. (2016). Urban rural differences in breast cancer in New Zealand. International Journal of Environmental Research & Public Health, 13(10), 1000. doi: 10.3390/ijerph13101000

Firth, M. J., Sharples, K. J., Hinder, V. A., Macapagal, J., Sarfati, D., Derrett, S. L., … Atmore, C., Keating, J. P., Jeffery, M., … Jackson, C. G. C. A., & Findlay, M. P. N. (2016). Methods of a national colorectal cancer cohort study: The PIPER Project. New Zealand Medical Journal, 129(1440), 25-36. Retrieved from https://www.nzma.org.nz/journal

Teng, A. M., Atkinson, J., Disney, G., Wilson, N., Sarfati, D., McLeod, M., & Blakely, T. (2016). Ethnic inequalities in cancer incidence and mortality: Census-linked cohort studies with 87 million years of person-time follow-up. BMC Cancer, 16, 755. doi: 10.1186/s12885-016-2781-4

Gurney, J., Chong, A., Culliford-Semmens, N., Tilton, E., Wilson, N. J., & Sarfati, D. (2016). The benefits and harms of rheumatic heart disease screening from the perspective of the screened population. International Journal of Cardiology, 221, 734-740. doi: 10.1016/j.ijcard.2016.07.025

Sarfati, D., Koczwara, B., & Jackson, C. (2016). The impact of comorbidity on cancer and its treatment. CA: A Cancer Journal for Clinicians, 66(4), 337-350. doi: 10.3322/caac.21342

Seneviratne, S., Lawrenson, R., Harvey, V., Ramsaroop, R., Elwood, M., Scott, N., Sarfati, D., & Campbell, I. (2016). Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology. BMC Cancer, 16, 129. doi: 10.1186/s12885-016-2177-5

Gurney, J. K., Stanley, J., Shaw, C., & Sarfati, D. (2016). Ethnic patterns of hypospadias in New Zealand do not resemble those observed for cryptorchidism and testicular cancer: Evidence of differential aetiology? Andrology, 4(1), 82-86. doi: 10.1111/andr.12121

Dew, K., Stubbe, M., Signal, L., Stairmand, J., Dennett, E., Koea, J., Simpson, A., Sarfati, D., … Holdaway, M. (2015). Cancer care decision making in multidisciplinary meetings. Qualitative Health Research, 25(3), 397-407. doi: 10.1177/1049732314553010

McDonald, A. M., Sarfati, D., Baker, M. G., & Blakely, T. (2015). Trends in Helicobacter pylori infection among Māori, Pacific, and European birth cohorts in New Zealand. Helicobacter, 20(2), 139-145. doi: 10.1111/hel.12186

Gurney, J. K., Sarfati, D., & Stanley, J. (2015). Obscure etiology, unusual disparity: The epidemiology of testicular cancer in New Zealand. Cancer Causes & Control, 26(4), 561-569. doi: 10.1007/s10552-015-0533-4

Gurney, J., Shaw, C., Stanley, J., Signal, V., & Sarfati, D. (2015). Cannabis exposure and risk of testicular cancer: A systematic review and meta-analysis. BMC Cancer, 15(1), 897. doi: 10.1186/s12885-015-1905-6

Cunningham, R., Sarfati, D., Stanley, J., Peterson, D., & Collings, S. (2015). Cancer survival in the context of mental illness: A national cohort study. General Hospital Psychiatry, 37, 501-506. doi: 10.1016/j.genhosppsych.2015.06.003

Signal, V., Sarfati, D., Cunningham, R., Gurney, J., Koea, J., & Ellison-Loschmann, L. (2015). Indigenous inequities in the presentation and management of stomach cancer in New Zealand: A country with universal health care coverage. Gastric Cancer, 18(3), 571-579. doi: 10.1007/s10120-014-0410-y

Sheerin, I., Green, T., Sarfati, D., & Cox, B. (2015). Projected costs of colorectal cancer treatment in New Zealand in the absence of population screening. New Zealand Medical Journal, 128(1408). Retrieved from https://www.nzma.org.nz/journal

Stairmand, J., Signal, L., Sarfati, D., Jackson, C., Batten, L., Holdaway, M., & Cunningham, C. (2015). Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: A systematic review. Annals of Oncology, 26, 1325-1332. doi: 10.1093/annonc/mdv025

Dew, K., Signal, L., Davies, C., Tavite, H., Hooper, C., Sarfati, D., Stairmand, J., & Cunningham, C. (2015). Dissonant roles: The experience of Māori in cancer care. Social Science & Medicine, 138, 144-151. doi: 10.1016/j.socscimed.2015.06.008

Blakely, T., Collinson, L., Kvizhinadze, G., Nair, N., Foster, R., Dennett, E., & Sarfati, D. (2015). Cancer care coordinators in stage III colon cancer: A cost-utility analysis. BMC Health Services Research, 15, 306. doi: 10.1186/s12913-015-0970-5

Gurney, J., Sarfati, D., & Stanley, J. (2015). The impact of patient comorbidity on cancer stage at diagnosis. British Journal of Cancer, 113, 1375-1380. doi: 10.1038/bjc.2015.355

Cunningham, R., Peterson, D., Sarfati, D., Stanley, J., & Collings, S. (2014). Premature mortality in adults using New Zealand psychiatric services. New Zealand Medical Journal, 127(1394). Retrieved from http://www.nzma.org.nz/journal

Meredith, I., Sarfati, D., Atkinson, J., & Blakely, T. (2014). Thyroid cancer in Pacific women in New Zealand. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Sarfati, D., Gurney, J., Stanley, J., Lim, B. T., & McSherry, C. (2014). Development of a pharmacy-based comorbidity index for patients with cancer. Medical Care, 52(7), 586-593. doi: 10.1097/mlr.0000000000000149

Sarfati, D., Gurney, J., Stanley, J., Salmond, C., Crampton, P., Dennett, E., … Pearce, N. (2014). Cancer-specific administrative data—based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. Journal of Clinical Epidemiology, 67(5), 586-595. doi: 10.1016/j.jclinepi.2013.11.012

Sarfati, D., Gurney, J., Stanley, J., & Koea, J. (2014). A retrospective cohort study of patients with stomach and liver cancers: The impact of comorbidity and ethnicity on cancer care and outcomes. BMC Cancer, 14, 821. doi: 10.1186/1471-2407-14-821

Hill, S., Sarfati, D., Robson, B., & Blakely, T. (2013). Indigenous inequalities in cancer: What role for health care? ANZ Journal of Surgery, 83(1-2), 36-41. doi: 10.1111/ans.12041

Chamberlain, J., Sarfati, D., Cunningham, R., Koea, J., Gurney, J., & Blakely, T. (2013). Incidence and management of hepatocellular carcinoma among Māori and non-Māori New Zealanders. Australian & New Zealand Journal of Public Health, 37(6), 520-526. doi: 10.1111/1753-6405.12108

Swart, E. M., Sarfati, D., Cunningham, R., Dennett, E., Signal, V., Gurney, J., & Stanley, J. (2013). Ethnicity and rectal cancer management in New Zealand. New Zealand Medical Journal, 126(1384). Retrieved from http://www.nzma.org.nz/journal

Blakely, T., Barendregt, J. J., Foster, R. H., Hill, S., Atkinson, J., Sarfati, D., & Edwards, R. (2013). The association of active smoking with multiple cancers: National census-cancer registry cohorts with quantitative bias analysis. Cancer Causes & Control, 24(6), 1243-1255. doi: 10.1007/s10552-013-0204-2

Rumball-Smith, J., Sarfati, D., Hider, P., & Blakely, T. (2013). Ethnic disparities in the quality of hospital care in New Zealand, as measured by 30-day rate of unplanned readmission/death. International Journal for Quality in Health Care, 25(3), 248-254. doi: 10.1093/intqhc/mzt012

Gurney, J., Sarfati, D., Stanley, J., Dennett, E., Johnson, C., Koea, J., Simpson, A., & Studd, R. (2013). Unstaged cancer in a population-based registry: Prevalence, predictors and patient prognosis. Cancer Epidemiology, 37(4), 498-504. doi: 10.1016/j.canep.2013.03.005

Gurney, J., Sarfati, D., Stanley, J., & Studd, R. (2013). Do ethnic patterns in cryptorchidism reflect those found in testicular cancer? Journal of Urology, 190(5), 1852-1857. doi: 10.1016/j.juro.2013.05.002

Rumball-Smith, J., Blakely, T., Sarfati, D., & Hider, P. (2013). The mismeasurement of quality by readmission rate: How blunt is too blunt an instrument? A quantitative bias analysis. Medical Care, 51(5), 418-424. doi: 10.1097/MLR.0b013e31828d1275

Nair, N., Sarfati, D., & Shaw, C. (2012). Population screening for abdominal aortic aneurysm: Evaluating the evidence against screening criteria [Review article]. New Zealand Medical Journal, 125(1350). Retrieved from http://www.nzma.org.nz/journal

Meredith, I., Sarfati, D., Ikeda, T., & Blakely, T. (2012). Cancer in Pacific people in New Zealand. Cancer Causes & Control, 23(7), 1173-1184. doi: 10.1007/s10552-012-9986-x

Sarfati, D. (2012). Review of methods used to measure comorbidity in cancer populations: No gold standard exists. Journal of Clinical Epidemiology, 65(9), 924-933. doi: 10.1016/j.jclinepi.2012.02.017

Shah, A. B., Sarfati, D., Blakely, T., Atkinson, J., & Dennett, E. R. (2012). Trends in colorectal cancer incidence rates in New Zealand, 1981-2004. ANZ Journal of Surgery, 82(4), 258-264. doi: 10.1111/j.1445-2197.2011.05995.x

Nair, N., Shaw, C., Sarfati, D., & Stanley, J. (2012). Abdominal aortic aneurysm disease in New Zealand: Epidemiology and burden between 2002 and 2006. New Zealand Medical Journal, 125(1350). Retrieved from http://www.nzma.org.nz/journal

Blakely, T., Soeberg, M., Carter, K., Costilla, R., Atkinson, J., & Sarfati, D. (2012). Bias in relative survival methods when using incorrect life-tables: Lung and bladder cancer by smoking status and ethnicity in New Zealand. International Journal of Cancer, 131(6), E974-E982. doi: 10.1002/ijc.27531

Meredith, I., Sarfati, D., Ikeda, T., Atkinson, J., & Blakely, T. (2012). High rates of endometrial cancer among Pacific women in New Zealand: The role of diabetes, physical inactivity, and obesity. Cancer Causes & Control, 23(6), 875-885. doi: 10.1007/s10552-012-9956-3

Blakely, T., Shaw, C., Atkinson, J., Cunningham, R., & Sarfati, D. (2011). Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004. Cancer Causes & Control, 22(9), 1307-1318. doi: 10.1007/s10552-011-9804-x

Brewer, N., Borman, B., Sarfati, D., Jeffreys, M., Fleming, S. T., Cheng, S., & Pearce, N. (2011). Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC Cancer, 11, 132. doi: 10.1186/1471-2407-11-132

Sarfati, D., Tan, L., Blakely, T., & Pearce, N. (2011). Comorbidity among patients with colon cancer in New Zealand. New Zealand Medical Journal, 124(1338). Retrieved from http://journal.nzma.org.nz/journal/124-1338/4766/content.pdf

Sarfati, D., Shaw, C., Blakely, T., Atkinson, J., & Stanley, J. (2011). Ethnic and socioeconomic trends in testicular cancer incidence in New Zealand. International Journal of Cancer, 128(7), 1683-1691. doi: 10.1002/ijc.25486

Sarfati, D., Blakely, T., & Pearce, N. (2010). Measuring cancer survival in populations: Relative survival vs cancer-specific survival. International Journal of Epidemiology, 39, 598-610. doi: 10.1093/ije/dyp392

Cormack, D., Sarfati, D., Harris, R., Robson, B., Shaw, C., & Blakely, T. (2010). Re: 'An overview of cancer and beliefs about the disease in indigenous people of Australia, Canada, New Zealand and the US' [Letter]. Australian & New Zealand Journal of Public Health, 34(1), 90-91. doi: 10.1111/j.1753-6405.2010.00481.x

Cunningham, R., Shaw, C., Blakely, T., Atkinson, J., & Sarfati, D. (2010). Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer, 10, 674. doi: 10.1186/1471-2407-10-674

Blakely, T., Carter, K., Wilson, N., Edwards, R., Woodward, A., Thomson, G., & Sarfati, D. (2010). If nobody smoked tobacco in New Zealand from 2020 onwards, what effect would this have on ethnic inequalities in life expectancy? New Zealand Medical Journal, 123(1320). Retrieved from http://journal.nzma.org.nz/journal/123-1320/4264/content.pdf

Hill, S., Sarfati, D., Blakely, T., Robson, B., Purdie, G., Dennett, E., Cormack, D., Dew, K., … Kawachi, I. (2010). Ethnicity and management of colon cancer in New Zealand: Do indigenous patients get a worse deal? Cancer, 116(13), 3205-3214. doi: 10.1002/cncr.25127

O'Brien, I., Britton, E. J., Sarfati, D., Naylor, W., Borman, B., Ellison-Loschmann, L., … Atkinson, C. (2010). The voice of experience: Results from Cancer Control New Zealand's first national cancer care survey. New Zealand Medical Journal, 123(1325). Retrieved from http://journal.nzma.org.nz/journal/123-1325/4419/content.pdf

Hill, S., Sarfati, D., Blakely, T., Robson, B., Purdie, G., Chen, J., Dennett, E., Cormack, D., Cunningham, R., Dew, K., … Kawachi, I. (2010). Survival disparities in indigenous and non-indigenous New Zealanders with colon cancer: The role of patient comorbidity, treatment and health service factors. Journal of Epidemiology & Community Health, 64(2), 117-123. doi: 10.1136/jech.2008.083816

Sarfati, D., Hill, S., Purdie, G., Dennett, E., & Blakely, T. (2010). How well does routine hospitalisation data capture information on comorbidity in New Zealand? New Zealand Medical Journal, 123(1310). Retrieved from http://journal.nzma.org.nz/journal/123-1310/4010/content.pdf

Jeffreys, M., Sarfati, D., Stevanovic, V., Tobias, M., Lewis, C., Pearce, N., & Blakely, T. (2009). Socioeconomic inequalities in cancer survival in New Zealand: The role of extent of disease at diagnosis. Cancer Epidemiology, Biomarkers & Prevention, 18(3), 915-921. doi: 10.1158/1055-9965.epi-08-0685

Sarfati, D., Hill, S., Blakely, T., Robson, B., Purdie, G., Dennett, E., Cormack, D., & Dew, K. (2009). The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: A retrospective cohort study. BMC Cancer, 9, 116. doi: 10.1186/1471-2407-9-116

Cunningham, R., Sarfati, D., Hill, S., Dennett, E., & O'Donnell, A. (2009). Colon cancer management in New Zealand: 1996-2003. New Zealand Medical Journal, 122(1294). Retrieved from http://journal.nzma.org.nz/journal/122-1294/3581/content.pdf

Cunningham, R., Sarfati, D., Hill, S., & Kenwright, D. (2008). An audit of colon cancer data on the New Zealand Cancer Registry. New Zealand Medical Journal, 121(1279). Retrieved from http://journal.nzma.org.nz/journal/121-1279/3191/content.pdf

Shaw, C., Blakely, T., Sarfati, D., Fawcett, J., & Peace, J. (2006). Trends in colorectal cancer mortality by ethnicity and socio-economic position in New Zealand, 1981-99: One country, many stories. Australian & New Zealand Journal of Public Health, 30(1), 64-70.

Sarfati, D., Blakely, T., Shaw, C., Cormack, D., & Atkinson, J. (2006). Patterns of disparity: Ethnic and socio-economic trends in breast cancer mortality in New Zealand. Cancer Causes & Control, 17, 671-678.

Shaw, C., Blakely, T., Sarfati, D., Fawcett, J., & Hill, S. (2005). Varying evolution of the New Zealand lung cancer epidemic by ethnicity and socioeconomic position (1981-1999). New Zealand Medical Journal, 118(1213). Retrieved from http://journal.nzma.org.nz/journal/118-1213/1411/content.pdf

Sarfati, D., Cox, B., Jones, R. W., Sopoaga, T., Rimene, C., & Paul, C. E. (2003). National audit of women with abnormal cervical smears in New Zealand. Australian & New Zealand Journal of Obstetrics & Gynaecology, 43, 152-156.

Sarfati, D., & Scott, K. (2001). The health of lone mothers in New Zealand. New Zealand Medical Journal, 114, 257-260.

Sarfati, D., & Scott, K. (2000). A moment in time: Selected results from the 1996/97 New Zealand health survey. Health Education & Behavior, 27, 296-306.

Scott, K., Sarfati, D., Tobias, M. I., & Haslett, S. J. (2000). A challenge to the cross-cultural validity of the SF-36 health survey: Factor structure in Maori, Pacific and New Zealand European ethnic groups. Social Science & Medicine, 51, 1655-1664.

Scott, K. M., Tobias, M. I., Sarfati, D., & Haslett, S. J. (1999). SF-36 Health Survey reliability, validity and norms for New Zealand. Australian & New Zealand Journal of Public Health, 23(4), 401-406.

Sarfati, D., Howden-Chapman, P., Woodward, A., & Salmond, C. (1998). Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed. Journal of Medical Screening, 5(3), 137-140.

Sarfati, D., Bates, M. N., Garrett, N., Baker, M. G., & Featherstone, D. (1997). Viral gastroenteritis testing capabilitites of New Zealand clinical laboratories. New Zealand Medical Laboratory Science, 125-127.

Sarfati, D., Bates, M. N., Garrett, N., & Baker, M. G. (1997). Acute gastroenteritis diagnosis practices of New Zealand General Practitioners. New Zealand Medical Journal, 110(1052), 354-356.

^ Top of page

Journal - Research Other

Gurney, J. K., McGlynn, K. A., Stanley, J., Merriman, T., Signal, V., Shaw, C., Edwards, R., … Sarfati, D. (2017). Risk factors for cryptorchidism. Nature Reviews Urology. Advance online publication. doi: 10.1038/nrurol.2017.90

Teng, A. M., Blakely, T., Baker, M. G., & Sarfati, D. (2017). The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: A birth cohort estimate [Short communication]. Gastric Cancer, 20(4), 752-755. doi: 10.1007/s10120-016-0671-8

Gurney, J. K., Chong, A., Culliford-Semmens, N., Tilton, E., Wilson, N. J., & Sarfati, D. (2017). High levels of rheumatic fever and sore throat awareness among a high-risk population screened for rheumatic heart disease. New Zealand Medical Journal, 130(1450), 107-110. Retrieved from http://www.nzma.org.nz/journal

Swinburn, B., Vandevijvere, S., on behalf of submitting health professors, including Hornblow, A., Taylor, B., Drummond, B., Murdoch, D., Mangin, D., Sarfati, D., Sellman, D., Sopoaga, F., Thomson, G., Abel, G., Hoek, J., Connor, J., Krebs, J., Mann, J., McCall, J., Broughton, J., Toop, L., Signal, L., Beckert, L., Farella, M., Baker, M., Keall, M., Skeaff, M., Thomson, M., Wilson, N., Chandler, N., Priest, P., Brunton, P., Crampton, P., Gendall, P., Howden-Chapman, P., Taylor, R., Edwards, R., Gauld, R., McGee, R., Mulder, R., Derrett, S., Hales, S., Pullon, S., & Blakely, T. (2017). Proposed new industry code on unhealthy food marketing to children and young people: Will it make a difference? New Zealand Medical Journal, 130(1450), 94-101. Retrieved from http://www.nzma.org.nz/journal

Sarfati, D., Shaw, C., McLeod, M., Blakely, T., & Bissett, I. (2016). Screening for colorectal cancer: Spoiled for choice? New Zealand Medical Journal, 129(1440), 120-128. Retrieved from http://www.nzma.org.nz/journal

Jackson, C. G. C. A., & Sarfati, D. (2016). How 'modifiable' are 'modifiable risk factors' for cancer? New Zealand Medical Journal, 129(1447), 7-9. Retrieved from http://www.nzma.org.nz/journal

Gurney, J., Sarfati, D., Stanley, J., Wilson, N., & Webb, R. (2015). The incidence of acute rheumatic fever in New Zealand, 2010-2013. New Zealand Medical Journal, 128(1417). Retrieved from https://www.nzma.org.nz/journal

Sarfati, D., & Robson, B. (2015). Equitable cancer control: Better data needed for indigenous people. Lancet Oncology, 16(15), 1442-1444. doi: 10.1016/S1470-2045(15)00295-8

Sarfati, D., Lynch, J., Bain, C., Blakely, T., Edwards, R., Jackson, R., … Priest, P., & Stanley, J. (2015). Teaching epidemiology in Australia and New Zealand: What are the core and advanced concepts for epidemiological practitioners and researchers? Australasian Epidemiologist, 22(1), 43-47.

Jackson, C., Ehrenberg, N., Frizelle, F., Sarfati, D., Balasingham, A., Pearse, M., … Bissett, I. (2014). Rectal cancer: Future directions and priorities for treatment, research and policy in New Zealand. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Sarfati, D., & Bissett, I. (2014). Response to Richardson and Potter’s “Screening for colorectal cancer and prostate cancer: challenges for New Zealand”: With authors’ reply. New Zealand Medical Journal, 127(1397). Retrieved from http://www.nzma.org.nz/journal

Hadorn, D., Wilson, N., Edwards, R., Blakely, T., & Sarfati, D. (2013). How to substantially increase recruitment in cancer trials in New Zealand. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal

Gurney, J., Sarfati, D., Dennett, E., & Koea, J. (2013). The completeness of cancer treatment data on the national health collections. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal

Blakely, T., Soeberg, M., & Sarfati, D. (2012). Investigating changes over time in socioeconomic gaps in cancer survival: Using differences in relative survival versus differences in excess mortality rates can give different answers [Letter]. Annals of Oncology, 23(1), 278-279. doi: 10.1093/annonc/mdr523

Rumball-Smith, J., & Sarfati, D. (2012). Readmission: Use with caution. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Rumball-Smith, J., & Sarfati, D. (2011). Improvement in the accuracy of hospital ethnicity data [Letter]. New Zealand Medical Journal, 124(1340). Retrieved from http://journal.nzma.org.nz/journal/124-1340/4827/content.pdf

Sarfati, D., Shaw, C., & Simmonds, S. (2010). Inequalities in cancer screening programmes [Commentary]. International Journal of Epidemiology, 39, 766-768. doi: 10.1093/ije/dyq039

Sarfati, D., Hill, S., Blakely, T., & Robson, B. (2010). Is bowel cancer screening important for Māori? [Editorial]. New Zealand Medical Journal, 123(1320). Retrieved from http://journal.nzma.org.nz/journal/123-1320/4266/content.pdf

Blakely, T., Sarfati, D., & Shaw, C. (2009). What proportion of cancer is due to obesity? [Editorial]. New Zealand Medical Journal, 122(1290). Retrieved from http://journal.nzma.org.nz/journal/122-1290/3478/content.pdf

Shaw, C., Cunningham, R., & Sarfati, D. (2008). From screening criteria to colorectal cancer screening: What can New Zealand learn from other countries? [Viewpoint]. New Zealand Medical Journal, 121(1279). Retrieved from http://journal.nzma.org.nz/journal/121-1279/3186/content.pdf

More publications...